Does Canadian pharmacy Viagra work for young men?

Wednesday, September 3rd, 2014 No Commented
Categorized Under: Medications

The prescription market for pharmaceutical products in Spain for the treatment of erectile dysfunction (the medications included were Canadian Viagra, Levitra and Cialis) was valued at approximately $5.1 billion in sales, during the year 2009. The annual growth rate for the sector was an average 6.4% between the years 2008 and 2009.

There are reasons why the country has limited generic penetration of medications and also why the big players have large profit margins when dealing with these medications. Since the introduction of the reference pricing system in Spain in the year 2010, there were numerous rounds of price cuts, and this led to minimal price differences between brand and generic medications. This was further fuelled by insufficient incentives of physicians and also the lack of requirements that were to be prescribed by the International Non-proprietary names.

However, the current Spanish government is making tremendous efforts to bring back the faith in the country’s national pharmaceutical market and is said to be working on some strategic plan to develop this sector by bringing in investments and creating job opportunities. Nevertheless, the plan is still in its very early ages and things are yet to be announced.

The European Commission then finally agreed to the request given by Indian manufacturers and consented to amend its regulations regarding to customs. This led to a halt of confiscation of generic medications that were being sent for sale in Africa and Latin America. A government official was reported saying that the trade commissioner of the European Union had categorically stated that the regulation 1383 of the European Commission shall be amended keeping the interests of India’s concern towards instances of seizures in mind.

According to IMS estimates, the total bill for hospital pharmacies in Spain accounts for 5,500 million euros. This figure by itself hardly says anything unless it is compared with the amount that the National Health System owes pharmaceutical companies. Spain’s public hospitals owe pharmaceutical firms an estimated 3,400 million euros (62 % of hospital spending on medicines for a year), carrying the debt on their books over nine months on average. And this figure continues to increase year-on-year.

To solve the serious problems that these delays are causing to the pharmaceutical sector, the President of Farmaindustria, Jess Acebillo, urged the authorities to take steps to achieve further rationalization of the portfolio of services offered by the National Health System. However the progression of hospital debt shows no signs of improvement. While at the beginning of this decade the debt was slightly over 900 million euros, now it has almost quadrupled.

For more info about Viagra and other medications go here: www.hqcanadianpharmacy.com